DefinitionThis section has been translated automatically.
EtiopathogenesisThis section has been translated automatically.
Occurs in gammopathy-associated amyloidosis, monoclonal B-cell proliferation such as plasmocytoma and M. Waldenström, but also in multiple myeloma and malignant lymphomas. Idiopathic genesis is also described. The amyloidogenic precursor proteins of AL amyloidoses are amino-terminal fragments of the variable regions of monoclonal immunoglobulin (Ig) light chains together with intact light chains. The process leading to amyloid formation is still largely unknown.
You might also be interested in
LocalizationThis section has been translated automatically.
Face (especially eyelids), scalp, tongue (macroglossia), palmae and plantae.
Clinical featuresThis section has been translated automatically.
In 30-50%, skin or mucous membrane infection occurs.
There are waxy or glassy, translucent, whitish to yellowish papules of varying size, preferably on the face (especially eyelids), scalp, tongue (dental impressions to macroglossia), palmae and plantae as well as in the genital area.
Partly formation of extensive plaques due to confluence of single standing foci, partly scleroderma aspect.
Possibly also increased skin fragility and blister formation (see also amyloidosis, blistering). Purpura, petechiae, ecchymoses (spontaneous spectacle haematoma = raccoon sign), see also amyloidosis, systemic.
Usually no itching. The main dermatological symptom is petechial or extensive bleeding. In older foci, hemosiderin deposits can be seen.
In the anogenital area formation of condyloma-like growths.
Notice! Asymptomatic papules and plaques that bleed in with little mechanical irritation are highly suspected of systemic AL-type amyloidosis!
HistologyThis section has been translated automatically.
Differential diagnosisThis section has been translated automatically.
TherapyThis section has been translated automatically.
Case report(s)This section has been translated automatically.
- 65-year-old patient undergoing inpatient internal medicine treatment for haemoptysis and pectanginous complaints. The clinical-dermatological presentation was due to extensive, bilateral, periorbital bleeding. No subjective symptoms like itching or pain. Otherwise slight exsiccation eczema.
- Laboratory findings: Pronounced paraproteinemia with free capa- and lambda fragments. Biopsy of the colon and mucous membrane: Detection of amyloid deposits (Congo red). Skin biopsy (cheek): Detection of amyloid deposits in subcutaneous vascular walls, subcutaneous connective tissue and along smooth muscles. Biochemical examinations: Classification of amyloidosis as L-lambda variant. Echocardiography: Wall thickened left ventricle with reduced ejection fraction of 60%, relaxation disorder. Iliac crest biopsy: No evidence of plasmocytoma.
- Therapy: Melphalan (Alkeran once/day 10 mg p.o. for 5 days) and methylprednisolone (Urbason once/day 50 mg p.o. for 5 days) in monthly cycles. Early significant decrease of relevant laboratory parameters.
LiteratureThis section has been translated automatically.
- Alim MA et al (1999) Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein. Clin Exp Immunol 118: 344-348
- Alim MA et al (1999) Structural relationship of lambda-type light chains with AL amyloidosis. Clin Immunol 90: 399-403
- Breathnach SM (1988) Amyloid and amyloidosis. J Am Acad Dermatol 18: 1-16
- Fracture resin D et al (2001) Accumulation of the xanthophyll lutein in skin amyloid deposits of systemic amyloidosis (al type). J Invest Dermatol 116: 196-197
- Buxbaum JN et al (1979) Amyloidosis of the AL Type. Clinical, Morphological and Biochemical Aspects of the Response to Therapy with Alkylating Agents and Prednisone. Am J Medicine 67: 867-878
- Fujigaki Y et al (2003) Longterm complete remission of AL-amyloid-related nephrotic syndrome. Clin Exp Nephrol 7: 250-253
- Laimer M et al (2004) Systemic AL-lambda amyloidosis with vascular fragility. JDDG 2: 934-939
- Modesto KM et al (2005) Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 26: 173-179
- Ruzicka T et al (1990) Cutaneous amyloidosis. Dermatologist 41: 245-255
- Sanders PW (2005) Management of paraproteinemic renal disease. Curr Opin Nephrol Hypertens 14: 97-103
- Swan N et al (2003) Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases. Am J Clin Pathol 120: 610-616
Incoming links (1)Amyloidosis of the ah type;
Outgoing links (20)Acuminate condyloma; Al amyloidosis renal changes; Alopecia (overview); Amyloidosis (overview); Amyloidosis systemic (overview); Bubble; Ecchymoses; Immunoglobulins; Macroglossia; Melphalan; ... Show all
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.